CORRESP Filing
Alps Group Inc
Date: Sept. 11, 2025 · CIK: 0002025774 · Accession: 0001493152-25-013057
AI Filing Summary & Sentiment
File numbers found in text: 333-284035
Show Raw Text
CORRESP
1
filename1.htm
VIA
EDGAR
September
11, 2025
Division
of Corporation Finance
Office
of Industrial Applications and Services
U.S.
Securities & Exchange Commission
100
F Street, NE
Washington,
D.C. 20549
Attention:
Conlon
Danberg
Lauren
Nguyen
Nudrat
Salik
Li
Xiao
Re:
Alps
Global Holding Pubco
Registration
Statement on Form F-4
File
No. 333-284035
Ladies
and Gentlemen:
Pursuant
to Rule 461 of Regulation C ("Rule 461") promulgated under the Securities Act of 1933, as amended, Alps Global Holding Pubco
(the "Registrant") and Alps Life Sciences Inc. (the "Co-Registrant") hereby request that the effectiveness of
the above-referenced registration statement on Form F-4, as amended (the "F-4 Registration Statement"), be accelerated to,
and that the F-4 Registration Statement become effective at, 5:00 p.m., Eastern Time on September 12, 2025, or as soon thereafter
as practicable. If there is any change in the acceleration request set forth above, the Registrant and Co-Registrant will promptly notify
you of the change, in which case the Registrant and Co-Registrant may be making an oral request of acceleration of the effectiveness
of the F-4 Registration Statement in accordance with Rule 461. Such request may be made by an executive officer of the Registrant and
Co-Registrant or by any attorney from their U.S. counsel, Law Offices of Jenny Chen-Drake.
Very
truly yours,
ALPS
GLOBAL HOLDING PUBCO
/s/
Tham Seng Kong
Tham
Seng Kong
Chief
Executive Officer of Alps Global Holding Pubco
Very
truly yours,
ALPS
LIFE SCIENCES INC.
/s/
Tham Seng Kong
Tham
Seng Kong
Group
Chief Executive Officer of Alps Life Sciences Inc.